Contents Link Navigation Link
TECHNOLOGY

Targeting, Attacking, and Eradicating Cancers®

Scientific Publications

Targeting, Attacking, and Eradicating Cancers®

  • A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination with Immune Checkpoint Inhibition in Refractory Colorectal Cancer: An Interim Safety Report
    Gastrointestinal Cancers Symposium 2019

    pdf Poster

  • A Phase I dose escalation trial evaluating the impact of an in situ Immunization strategy with Intra-Tumoral Injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions.
    ESMO IO 2018

    pdf Poster

  • Single intravenous preoperative administration of the oncolytic vaccinia virus Pexa-Vec to prime anti-tumor immunity
    ASCO 2018

    pdf Poster

  • Combination of oncolytic vaccinia virus and immune checkpoint blockade overcomes resistance to immunotherapy in renal cell carcinoma
    AACR 2018

    pdf Poster

  • Phase 2 Trial of Pexa-Vec, an Oncolytic and Immunotherapeutic Vaccinia Virus, in Patients with Metastatic, Refractory, Renal Cell Carcinoma (RCC)
    GU ASCO 2018

    jpg Poster